We are live on ! Find out more
SKYE icon

Skye Bioscience

58 hedge funds and large institutions have $85.3M invested in Skye Bioscience in 2025 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

117% more capital invested

Capital invested by funds: $39.3M → $85.3M (+$46M)

111% more call options, than puts

Call options by funds: $388K | Put options by funds: $184K

13.87% less ownership

Funds ownership: 79.73%65.86% (-14%)

19% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 16

23% less funds holding

Funds holding: 7558 (-17)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

55% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 29

Holders
58
Holders Change
-17
Holders Change %
-22.67%
% of All Funds
0.76%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
13
Increased
13
Reduced
16
Closed
29
Calls
$388K
Puts
$184K
Net Calls
+$204K
Net Calls Change
+$141K

SKYE Hedge Fund Activity: Q2 2025 in Review

58 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Skye Bioscience (SKYE) for Q2 2025, worth a combined $85.3M — up 117% from $39.3M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of SKYE and 13 opened new positions — a net loss of 16 holders — while 16 trimmed existing stakes and 13 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $974K. The largest seller was Sphera Funds Management, cutting an estimated $1.94M.

  • 58 institutional investors held Skye Bioscience (SKYE) as of Q2 2025, down from 75 in Q1 2025.
  • Funds reported $85.3M of Skye Bioscience stock for Q2 2025, up 117% quarter-over-quarter.
  • 13 funds opened new Skye Bioscience positions in Q2 2025 and 29 closed out, a net change of -16 holders.
  • The largest Skye Bioscience buyer in Q2 2025 was Millennium Management, an estimated $974K added.
  • The largest Skye Bioscience seller in Q2 2025 was Sphera Funds Management, an estimated $1.94M sold.

Based on aggregated 13F filings for Q2 2025.